Ashira D Blazer1, Robert M Clancy2. 1. Division of Rheumatology, Department of Medicine, New York University School of Medicine, 550 First Avenue, MSB 611, New York, NY, 10016, USA. ashira.blazer@nyumc.org. 2. Division of Rheumatology, Department of Medicine, New York University School of Medicine, 550 First Avenue, MSB 611, New York, NY, 10016, USA.
Abstract
PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) confers up to a 50-fold increased risk of cardiovascular disease (CVD), and African Americans with SLE experience accelerated damage accrual and doubled cardiovascular risk when compared to their European American counterparts. RECENT FINDINGS: Genome-wide association studies have identified a substantial signal at 22q13, now assigned to variation at apolipoprotein L1 (APOL1), which has associated with progressive nondiabetic nephropathy, cardiovascular disease, and many immune-associated renal diseases, including lupus nephritis. We contend that alterations in crucial APOL1 intracellular pathways may underpin associated disease states based on structure-functional differences between variant and ancestral forms. While ancestral APOL1 may be a key driver of autophagy, nonconserved primary structure changes result in a toxic gain of function with attenuation of autophagy and an unsupervised pore-forming feature. Thus, the divergent intracellular biological pathways of ancestral and variant APOL1 may explain a worsened prognosis as demonstrated in SLE.
PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) confers up to a 50-fold increased risk of cardiovascular disease (CVD), and African Americans with SLE experience accelerated damage accrual and doubled cardiovascular risk when compared to their European American counterparts. RECENT FINDINGS: Genome-wide association studies have identified a substantial signal at 22q13, now assigned to variation at apolipoprotein L1 (APOL1), which has associated with progressive nondiabetic nephropathy, cardiovascular disease, and many immune-associated renal diseases, including lupus nephritis. We contend that alterations in crucial APOL1 intracellular pathways may underpin associated disease states based on structure-functional differences between variant and ancestral forms. While ancestral APOL1 may be a key driver of autophagy, nonconserved primary structure changes result in a toxic gain of function with attenuation of autophagy and an unsupervised pore-forming feature. Thus, the divergent intracellular biological pathways of ancestral and variant APOL1 may explain a worsened prognosis as demonstrated in SLE.
Authors: Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays Journal: Nature Date: 2003-03-06 Impact factor: 49.962
Authors: Krishna K Singh; Fina Lovren; Yi Pan; Adrian Quan; Azza Ramadan; Pratiek N Matkar; Mehroz Ehsan; Paul Sandhu; Laura E Mantella; Nandini Gupta; Hwee Teoh; Matteo Parotto; Arata Tabuchi; Wolfgang M Kuebler; Mohammed Al-Omran; Toren Finkel; Subodh Verma Journal: J Biol Chem Date: 2014-12-19 Impact factor: 5.157
Authors: Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler Journal: J Am Soc Nephrol Date: 2011-10-13 Impact factor: 10.121
Authors: Russell Thomson; Giulio Genovese; Chelsea Canon; Daniella Kovacsics; Matthew K Higgins; Mark Carrington; Cheryl A Winkler; Jeffrey Kopp; Charles Rotimi; Adebowale Adeyemo; Ayo Doumatey; George Ayodo; Seth L Alper; Martin R Pollak; David J Friedman; Jayne Raper Journal: Proc Natl Acad Sci U S A Date: 2014-05-07 Impact factor: 11.205
Authors: Lijun Ma; Gregory S Shelness; James A Snipes; Mariana Murea; Peter A Antinozzi; Dongmei Cheng; Moin A Saleem; Simon C Satchell; Bernhard Banas; Peter W Mathieson; Matthias Kretzler; Ashok K Hemal; Lawrence L Rudel; Snezana Petrovic; Allison Weckerle; Martin R Pollak; Michael D Ross; John S Parks; Barry I Freedman Journal: J Am Soc Nephrol Date: 2014-07-10 Impact factor: 10.121
Authors: Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp Journal: Kidney Int Date: 2012-07-25 Impact factor: 10.612
Authors: Zhongyang Zhang; Zeguo Sun; Jia Fu; Qisheng Lin; Khadija Banu; Kinsuk Chauhan; Marina Planoutene; Chengguo Wei; Fadi Salem; Zhengzi Yi; Ruijie Liu; Paolo Cravedi; Haoxiang Cheng; Ke Hao; Philip J O'Connell; Shuta Ishibe; Weijia Zhang; Steven G Coca; Ian W Gibson; Robert B Colvin; John Cijiang He; Peter S Heeger; Barbara Murphy; Madhav C Menon Journal: J Clin Invest Date: 2021-11-15 Impact factor: 14.808
Authors: Ashira Blazer; Yingzhi Qian; Martin Paul Schlegel; Huda Algasas; Jill P Buyon; Ken Cadwell; Michael Cammer; Sean P Heffron; Feng-Xia Liang; Shilpi Mehta-Lee; Timothy Niewold; Sara E Rasmussen; Robert M Clancy Journal: Front Genet Date: 2022-09-27 Impact factor: 4.772